Hidden in Plain Sight: Identifying Women Living in the United States Who Could Benefit From HIV Preexposure Prophylaxis
- 1 November 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 222 (9), 1428-1431
- https://doi.org/10.1093/infdis/jiz416
Abstract
HIV preexposure prophylaxis (PrEP) with oral tenofovir/emtricitabine is an effective means of decreasing human immunodeficiency virus (HIV) acquisition among women. However, few women are prescribed and are taking PrEP. This article offers perspectives on barriers to use and strategies to increase uptake among women.Keywords
Funding Information
- National Institutes of Health (K23MH107316)
- Harvard University Center for AIDS Research (P30AI060354)
This publication has 20 references indexed in Scilit:
- Brief Report: PrEP Eligibility Among At-Risk Women in the Southern United States: Associated Factors, Awareness, and AcceptabilityJAIDS Journal of Acquired Immune Deficiency Syndromes, 2019
- Unequal Declines in Absolute and Relative Disparities in HIV Diagnoses Among Black Women, United States, 2008 to 2016American Journal of Public Health, 2018
- HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016Mmwr-Morbidity and Mortality Weekly Report, 2018
- Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015Annals of Epidemiology, 2018
- Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC)AIDS and Behavior, 2018
- Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US WomenJournal of AIDS & Clinical Research, 2017
- HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015New England Journal of Medicine, 2016
- HIV Diagnoses and Prevalence in the Southern Region of the United States, 2007–2010Journal of Community Health, 2012
- HIV in Persons Born Outside the United States, 2007-2010Published by American Medical Association (AMA) ,2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenNew England Journal of Medicine, 2012